Xiao Lv

Xiao Lv is a Postdoctoral Research Fellow in the Davids’ Lab, focusing on antibody drug development for Chronic Lymphocytic Leukemia (CLL). She holds an M.D. from Shandong University (2013) and completed clinical training in hematology at Shandong Provincial Hospital. Her research spans diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and CLL, with expertise in translational oncology and clinical trial design.

Education:

• M.D., Shandong University, China, 2013

Research Interests: Targeting CLL through antibody-based therapies, molecular mechanisms of lymphoma progression, and improving clinical outcomes via precision medicine approaches. Active in collaborative studies on immune-oncology and drug resistance.

Labs/Teams: Current member of the Davids’ Lab, engaged in interdisciplinary research bridging laboratory science and clinical application.